Hongsheng Capital
VC Fund
Xinyuan, China
Hongsheng Capital is a VC fund in Xinyuan focused on Manufacturing and Medical. Hudson Capital is a professional investment institution operating independently in the market.
- Total investments:
- 16
- Last investment:
- Lead investor:
- 25%
Last updated:
For AI agents: llms.txt
Industries Hongsheng Capital invests in
Stages Hongsheng Capital invests in
Countries Hongsheng Capital invests in
Investment Focus
Industry
- Manufacturing 5 (31%)
- Medical 4 (25%)
- Electronics 4 (25%)
- Semiconductor 4 (25%)
- Biopharma 3 (19%)
Stage
- Series C 5 (31%)
- Series B 4 (25%)
- Seed 3 (19%)
- Series A 2 (13%)
- Funding Round 1 (6%)
Country
- China 12 (75%)
- United States 1 (6%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Junhemeng Biopharmaceutical
|
Junhemeng is a research and development company of recombinant protein drugs. | $29.5M / Series C / Jun 08, 2026 | |
|
Tianhuiyi Enterprise
|
Tianhuiyi Enterprise focuses on the blood purification sector. | Venture - Series Unknown / Apr 10, 2026 | |
Xinsheng Semiconductor
|
Xinsheng Semiconductor is a semiconductor and discrete device manufacturing company. They provide research, development, and sales of acoustic filters and RF front-end module products. They provide products such as filters, duplexers, multiplexers, and modules below 6 GHz. They also provide technical services. | $38M / Series C / Dec 08, 2025 | |
|
Xinsheng Semiconductor
|
Xinsheng Semiconductor is a semiconductor and discrete device manufacturing company. They provide research, development, and sales of acoustic filters and RF front-end module products. They provide products such as filters, duplexers, multiplexers, and modules below 6 GHz. They also provide technical services. | $40.1M / Series B / Aug 11, 2025 | |
|
Tianhuiyi Enterprise
|
Tianhuiyi Enterprise focuses on the blood purification sector. | Seed / Jun 01, 2025 | |
|
Junhemeng Biopharmaceutical
|
Junhemeng is a research and development company of recombinant protein drugs. | $28.1M / Series B / Sep 09, 2024 | |
Cellbri
|
Cellbri is a manufacturing company that produces and sells automated CGT industrial instruments for cell processing programs. | $27.6M / Series B / Jun 14, 2024 | |
Arnatar Therapeutics
|
Arnatar Therapeutics is a biopharmaceutical company that specializes in the development of novel nucleic acid medications. | $52M / Series A / Apr 08, 2024 | |
Optoxuhai
|
Optoxuhai is a micro-nano optical hybrid integration platform that offers complete set of device and module solutions(gas laser series, optical cell series and photodetector series) for detection based on spectral analysis. | Series A / Sep 12, 2023 | |
Jiamuyao Medical
|
Jiamuyao Medical specialized in developing an energy platform for the comprehensive treatment of complex intravascular lesions. | Seed / Jul 24, 2023 | |
| See all 16 investments → | |||
Co-Investors
3E Bioventures
3 deals together
China National Building Material
3 deals together
SDIC Unity Capital
3 deals together
Shang Qi Capital
3 deals together
China Development Bank Capital
2 deals together
China Life Investment Holding
2 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Hongsheng Capital invest in?
Hongsheng Capital invests primarily in Manufacturing, Medical and Electronics startups, most often at Series C and Series B stage. Most of the 16 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Hongsheng Capital last invest?
The most recent investment recorded for Hongsheng Capital closed in Jun 2026. Shizune tracks 16 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
